![Laura Bessen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 30/06/2026
Laura Bessen is currently an Independent Director at C4 Therapeutics, Inc. since 2022.
Formerly, Dr. Bessen was an Independent Director at Artiva Biotherapeutics, Inc. from 2022 to 2025 and served as Vice President & Head-US Medical at Bristol Myers Squibb Co. from 2001 to 2016.
Education includes undergraduate studies at the State University of New York at Binghamton and a doctorate from New York University School of Medicine.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 24/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| C4 THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/08/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
| ARTIVA BIOTHERAPEUTICS, INC. | Director/Miembro de la Junta | 24/06/2025 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2016 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
State University of New York at Binghamton
 State University of New York at Binghamton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
C4 Therapeutics, Inc.
 C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. Pharmaceuticals: OtherHealth Technology Operates as a biotechnology company which develops natural killer cell-based therapies for patients suffering from autoimmune diseases and cancers | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
